Literature DB >> 28753597

Urotensin 2 in Kawasaki disease pathogenesis.

Cassidy Y Huang1, Jane C Burns1, Chisato Shimizu1.   

Abstract

BackgroundGenetic variation in calcium signaling pathways is associated with Kawasaki disease (KD) susceptibility and coronary artery aneurysms (CAA). Expression quantitative trait locus analysis for KD-associated variants in calcium/sodium channel gene solute carrier family 8 member 1 (SLC8A1) revealed an effect on expression of urotensin 2 (UTS2). We speculated that UTS2 is influenced by genetic variation in SLC8A1 and contributes to disease pathogenesis.MethodsWe measured levels of UTS2 and its receptor in blood and tissues using quantitative reverse transcription-polymerase chain reaction, enzyme-linked immunosorbent assay, and immunohistochemical staining.ResultsUTS2 transcript levels were higher in the whole blood of subjects with KD homozygous for three risk alleles in SLC8A1 (P=0.002-0.006). Increased levels of plasma UTS2 varied as a function of SLC8A1 genotype (P=0.008-0.04). UTS2 and UTS2 receptor were expressed in mononuclear inflammatory cells and spindle-shaped cells in the coronary arterial wall of a patient suffering from KD with CAA and in a femoral endarterectomy specimen from an adult patient with peripheral aneurysms following KD in childhood.ConclusionHost genetics influences UTS2 levels, which may contribute to inflammation and cardiovascular damage in KD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28753597     DOI: 10.1038/pr.2017.183

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  30 in total

Review 1.  Genetics of Kawasaki disease: what we know and don't know.

Authors:  Yoshihiro Onouchi
Journal:  Circ J       Date:  2012-06-07       Impact factor: 2.993

2.  Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy.

Authors:  T Asano; S Ogawa
Journal:  Scand J Immunol       Date:  2000-01       Impact factor: 3.487

Review 3.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

Review 4.  Molecular genetics of Kawasaki disease.

Authors:  Yoshihiro Onouchi
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

5.  Nationwide survey of Kawasaki disease and acute rheumatic fever.

Authors:  K A Taubert; A H Rowley; S T Shulman
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

Review 6.  Kawasaki Disease.

Authors:  Jane W Newburger; Masato Takahashi; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2016-04-12       Impact factor: 24.094

7.  Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets.

Authors:  Kok Loon Wong; June Jing-Yi Tai; Wing-Cheong Wong; Hao Han; Xiaohui Sem; Wei-Hseun Yeap; Philippe Kourilsky; Siew-Cheng Wong
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

8.  Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated With Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities.

Authors:  Chisato Shimizu; Hariklia Eleftherohorinou; Victoria J Wright; Jihoon Kim; Martin P Alphonse; James C Perry; Rolando Cimaz; David Burgner; Nagib Dahdah; Long T Hoang; Chiea Chuen Khor; Andrea Salgado; Adriana H Tremoulet; Sonia Davila; Taco W Kuijpers; Martin L Hibberd; Todd A Johnson; Atsushi Takahashi; Tatsuhiko Tsunoda; Michiaki Kubo; Toshihiro Tanaka; Yoshihiro Onouchi; Rae S M Yeung; Lachlan J M Coin; Michael Levin; Jane C Burns
Journal:  Circ Cardiovasc Genet       Date:  2016-11-21

9.  Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.

Authors:  M Terai; T Jibiki; A Harada; Y Terashima; K Yasukawa; S Tateno; H Hamada; S Oana; H Niimi; K Matsushima
Journal:  J Leukoc Biol       Date:  1999-05       Impact factor: 4.962

10.  Differentiation potential of CD14+ monocytes into myofibroblasts in patients with systemic sclerosis.

Authors:  Nadine Binai; Steven O'Reilly; Bridget Griffiths; Jacob M van Laar; Thomas Hügle
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.